Skip to main content

Evaluation, Diagnosis, and Management of Congenital Muscular Dystrophy

CPG
Date: Friday, July 12, 2024

Overview

This updated guideline from the American Academy of Neurology and American Association of Neuromuscular & Electrodiagnostic Medicine revises the 2015 recommendations for the diagnosis and management of congenital muscular dystrophy. A patient-friendly summary and educational materials for clinicians are also available on their website.

Get the CPG

Members Only Content

Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.

Yes, sign me up for an APTA membership!

Already a member? Log in

Share This
Resource Details

Date: July 12, 2024
Contact:  practice@apta.org
Content Type:  CPG

Symptoms & Conditions

Muscular Dystrophy

Patient Age

Preschool Child (2-5)

You Might Also Like...

CPG

Evaluation, Diagnosis, and Management of Facioscapulohumeral Muscular Dystrophy

Jul 12, 2024

CPG

Respiratory Management of Patients With Neuromuscular Weakness

Mar 13, 2023

This joint guideline by the American College of Chest Physicians and Canadian Thoracic Society covers the prevention of acute exacerbations experienced

Clinical Summary

Muscular Dystrophy (MD): Duchenne and Becker (DBMD)

Jan 19, 2014

PTs help people with DBMD improve their quality of life.